Olmesat 20

Olmesat 20 contains Olmesartan medoxomil 20 mg. Prescription required.

Treatment of hypertension (high blood pressure); may be used alone or in combination with other antihypertensives to reduce risk of cardiovascular events associated with uncontrolled BP.

Olmesartan medoxomil is an angiotensin II receptor blocker (ARB). It blocks AT1 receptors, preventing angiotensin II–mediated vasoconstriction and aldosterone release, thereby lowering blood pressure and reducing strain on the heart.

Tablet for oral use. Take once daily at the same time each day, with or without food, as prescribed by a doctor. Swallow whole with water; do not stop suddenly without medical advice.

dizziness, headache, fatigue, low blood pressure, increased potassium (hyperkalemia), nausea, diarrhea, back pain

Not recommended in pregnancy (can harm the unborn baby); stop and consult a doctor if pregnancy occurs. Use caution in kidney disease, liver impairment, dehydration/volume depletion, and in patients with high potassium; periodic monitoring of blood pressure, kidney function and serum potassium is advised. Rare: severe sprue-like enteropathy (chronic diarrhea/weight loss) has been reported with olmesartan—seek medical advice if persistent diarrhea occurs. May cause dizziness—use caution while driving.

Potassium supplements/potassium-sparing diuretics (e.g., spironolactone, amiloride), ACE inhibitors or aliskiren (increased risk of kidney problems/hyperkalemia; avoid especially in diabetes), NSAIDs (e.g., ibuprofen, diclofenac) may reduce antihypertensive effect and worsen kidney function, lithium (increased lithium levels/toxicity), other antihypertensives (additive BP lowering).

Store below 30°C in a cool, dry place, protected from light and moisture. Keep in original blister pack and out of reach of children.

Olmetime 20 Tablet, Olmecip 20 Tablet, Olmezest 20 Tablet, Olkem 20 Tablet, Olmark 20 Tablet